1. |
Exline MC, Crouser ED.Mitochondrial dysfunction during sepsis:still more questions than answers.Crit Care Med, 2011, 39:1216-1223.
|
2. |
Singer M.Mitochondrial function in sepsis:acute phase versus multiple organ failure.Crit Care Med, 2007, 35(9 Suppl):S441-S448.
|
3. |
Rocha M, Herance R, Rovira S, et al.Mitochondrial dysfunction and antioxidant therapy in sepsis.Infect Disord Drug Targets, 2012, 12:161-178.
|
4. |
Rittirsch D, Huber-Lang MS, Flierl MA, et al.Immunodesign of experimental sepsis by cecal ligation and puncture.Nat Protoc, 2009, 4:31-36.
|
5. |
Levy MM, Fink MP, Marshall JC, et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med, 2003, 31:1250-1256.
|
6. |
Levy RJ.Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis.Shock, 2007, 28:24-28.
|
7. |
Yorns WR Jr, Hardison HH.Mitochondrial dysfunction in migraine.Semin Pediatr Neurol, 2013, 20:188-193.
|
8. |
Boisrame-Helms J, Kremer H, Schini-Kerth V, et al.Endothelial dysfunction in sepsis.Curr Vasc Pharmacol, 2013, 11:150-160.
|
9. |
党晓燕, 秦勇, 丁新爱, 等.NT-proBNP、血小板及胆固醇水平与脓毒症预后的相关性.临床误诊误治, 2013, 26:80-83.
|
10. |
Fink MP.Bench-to-bedside review:High-mobility group box 1 and critical illness.Crit Care, 2007, 11:229.
|
11. |
陈昌勤, 张召才, 严静.脓毒症和心肌线粒体损伤.中国危重病急救医学, 2007, 19:630-632.
|
12. |
荣子杰, 杨联军, 朱立新, 等.氧化应激诱导髓核细胞凋亡中细胞内活性氧及线粒体膜电位的变化.实用医学杂志, 2014, 30:193-195.
|
13. |
Brealey D, Brand M, Hargreav I, et al.Association between mitochondrial dysfunction and severity and outcome of septic shock.Lancet, 2002, 7:219-223.
|